ArticleSignal transduction and targeted therapy2025

Anti-MSLN chimeric antigen receptor-like NK cell therapy with tumor-penetrating capacity (uCAR-like NK) for solid tumors.

Mengchao An et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.